Associations of diabetic neuropathy evaluated by HDN-1000 with glycemic control and other clinical parameters: A observational study

Associations of diabetic neuropathy evaluated by HDN-1000 with glycemic control and other clinical parameters: A observational study - Diabetic neuropathy and glycemic control

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220277

Enrollment

800

Registered

2017-02-20

Start date

2017-02-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Between January 2015 and October 2016, a total of 740 individuals who had an examination for DN were included.

Exclusion criteria

Exclusion criteria: Patients younger than 20 years, with other neurological disorders than DN were excluded. Patients who could not undergo an examination for DN because of lower extremity edema and injuries were also excluded.

Design outcomes

Primary

Measure	Time frame
Sural nerve conduction velocity (SNCV) and amplitude (SNAP).	—

Secondary

Measure	Time frame
Blood glucose levels, HbA1c, blood pressure, lipid profile, and indicators of arteriosclerosis such as ABI, TBI, and baPWV.	—

Countries

Japan

Contacts

Public ContactHidetaka Hamasaki

Hamasaki Clinic

info@hamasakiclinic.jp+81-99-250-3535

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026